scholarly journals Clinical relevance of St. John's wort drug interactions revisited

2020 ◽  
Vol 177 (6) ◽  
pp. 1212-1226 ◽  
Author(s):  
Simon Nicolussi ◽  
Jürgen Drewe ◽  
Veronika Butterweck ◽  
Henriette E. Meyer zu Schwabedissen
2003 ◽  
Vol 44 (4) ◽  
pp. 271-282 ◽  
Author(s):  
Paul Hammerness ◽  
Ethan Basch ◽  
Catherine Ulbricht ◽  
E.-P. Barrette ◽  
Ivo Foppa ◽  
...  

2010 ◽  
pp. 273-290
Author(s):  
Matthew D. Krasowski ◽  
John L. Blau

2002 ◽  
Vol 54 (4) ◽  
pp. 349-356 ◽  
Author(s):  
L. Henderson ◽  
Q. Y. Yue ◽  
C. Bergquist ◽  
B. Gerden ◽  
P. Arlett

2005 ◽  
Vol 16 (3) ◽  
pp. 181-186 ◽  
Author(s):  
Edward Mills ◽  
Victor Montori ◽  
Dan Perri ◽  
Elizabeth Phillips ◽  
Gideon Koren

The use of natural health products (NHPs) within the HIV community is high. Several NHPs have demonstrated interactions with HIV medications that could contribute to drug failure. We aimed to conduct a systematic review of clinical trials examining NHP–HIV drug interactions and their methodological characteristics. We searched electronic databases and unpublished resources independently, in duplicate. Nine studies were identified, eight clinical pharmacokinetics trials and one population-pharmacokinetics trial. Investigators studied four different herbal medicines (St John's wort, garlic, goldenseal and milk thistle) and one vitamin (vitamin C). Significant interactions were observed with St John's wort, garlic and vitamin C. However, methodological challenges exist to making the results directly generalizable to patients. This review finds that important drug level changes exist when NHPs are combined with HIV medications. Considering patient values and the implications of these studies, further research is urgently required to determine the extent of interactions with other commonly used NHPs.


Sign in / Sign up

Export Citation Format

Share Document